摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(3-cyclopentyloxy-4-methoxyphenyl)tetrahydrothiophene 1,1-dioxide

中文名称
——
中文别名
——
英文名称
3-(3-cyclopentyloxy-4-methoxyphenyl)tetrahydrothiophene 1,1-dioxide
英文别名
3-(3-Cyclopentyloxy-4methoxyphenyl)tetrahydrothiophene 1,1-dioxide;3-(3-cyclopentyloxy-4-methoxyphenyl)thiolane 1,1-dioxide
3-(3-cyclopentyloxy-4-methoxyphenyl)tetrahydrothiophene 1,1-dioxide化学式
CAS
——
化学式
C16H22O4S
mdl
——
分子量
310.414
InChiKey
YFPWHKJROIUPBP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    21
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    61
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    3-(3-cyclopentyloxy-4-methoxyphenyl)-4,5-dihydrothiophene 1,1-dioxide 、 硼氢化钠Dichlorocobalt hexahydrate 二氯甲烷乙酸乙酯甲苯 作用下, 以 乙醇 为溶剂, 反应 6.0h, 以to give 3-(3-cyclopentyloxy-4methoxyphenyl)tetrahydrothiophene 1,1-dioxide (0.74 g) in the form of a white solid, m.p. 89°-90° C. [Elemental analysis: C,61.8; H,7.10; S,10.4%; calculated: C,61.91; H,7.1; S,10.33%]的产率得到3-(3-cyclopentyloxy-4-methoxyphenyl)tetrahydrothiophene 1,1-dioxide
    参考文献:
    名称:
    1-Alkoxy-2-(alkoxy- or cycloalkoxy-)-4-(cyclothioalkyl- or
    摘要:
    本发明涉及1-烷氧基-2-(烷氧基或环烷氧基)-4-(环硫烷基或环硫烯基)-苯化合物,其抑制环磷酸腺苷磷酸二酯酶或肿瘤坏死因子(TNF),并且在治疗患有可通过抑制环磷酸腺苷磷酸二酯酶或TNF产生而调节的疾病状态的患者中,通过向患者施用该化合物具有用途。本发明还涉及制备这些化合物、含有这些化合物的制药组合物以及它们的药物使用方法。
    公开号:
    US05541219A1
点击查看最新优质反应信息

文献信息

  • 1-ALKOXY-(2-ALKOXY- OR CYCLOALKOXY)-4-(CYCLO THIOALKYL- OR CYCLOTHIOALKENYL)BENZENES AS INHIBITORS OF CYCLIC AMP PHOSPHODIESTERASE AND TUMOUR NECROSIS FACTOR
    申请人:RHONE-POULENC RORER LIMITED
    公开号:EP0629197A1
    公开(公告)日:1994-12-21
  • US5541219A
    申请人:——
    公开号:US5541219A
    公开(公告)日:1996-07-30
  • [EN] 1-ALKOXY-(2-ALKOXY- OR CYCLOALKOXY)-4-(CYCLO THIOALKYL- OR CYCLOTHIOALKENYL)BENZENES AS INHIBITORS OF CYCLIC AMP PHOSPHODIESTERASE AND TUMOUR NECROSIS FACTOR
    申请人:——
    公开号:WO1993018024A1
    公开(公告)日:1993-09-16
    [EN] This invention is directed to 1-alkoxy-2-(alkoxy- or cycloalkyloxy-)-4-(cyclothioalkyl- or cyclothioalkenyl-)benzene compounds that inhibit cyclic AMP phosphodiesterase or tumor necrosis factor (TNF) and are useful in treating patients suffering from disease state capable of being modulated by inhibiting production of cyclic AMP phosphodiesterase or TNF by administering the compound to the patient. The invention is also directed to the preparation of these compounds, pharmaceutical compositions containing these compounds and methods for their pharmaceutical use.
    [FR] L'invention concerne des composés de 1-alcoxy-2-(alcoxy- ou cycloalkylosy)-4- (cyclothioalkyl- ou cyclothioalcenyl-)benzène qui inhibent la phosphodiestérase AMP cyclique ou le facteur de nécrose tumorale (FNT) et qui sont utiles dans le traitement de patients souffrant d'états pathologiques pouvant être modulés par l'inhibition de la production de la phosphodiestérase AMP cyclique ou le FNT en administrant le composé aux patients. L'invention concerne également la préparation de ces composés, les compositions pharmaceutiques contenant ces composés et les procédés de leur application pharmaceutique.
  • 1-Alkoxy-2-(alkoxy- or cycloalkoxy-)-4-(cyclothioalkyl- or
    申请人:Rhone-Poulenc Rorer Limited
    公开号:US05541219A1
    公开(公告)日:1996-07-30
    This invention is directed to 1-alkoxy-2-(alkoxy- or cycloalkyloxy-)-4-(cyclothioalkyl- or cyclothioalkenyl-)benzene compounds that inhibit cyclic AMP phosphodiesterase or tumor necrosis factor (TNF) and are useful in treating patients suffering from disease state capable of being modulated by inhibiting production of cyclic AMP phosphodiesterase or TNF by administering the compound to the patient. The invention is also directed to the preparation of these compounds, pharmaceutical compositions containing these compounds and methods for their pharmaceutical use.
    本发明涉及1-烷氧基-2-(烷氧基或环烷氧基)-4-(环硫烷基或环硫烯基)-苯化合物,其抑制环磷酸腺苷磷酸二酯酶或肿瘤坏死因子(TNF)并且适用于通过向患者投药该化合物来治疗能够通过抑制环磷酸腺苷磷酸二酯酶或TNF的产生而调节的疾病状态的患者。本发明还涉及制备这些化合物、含有这些化合物的药物组合物以及它们的药物使用方法。
查看更多